Förster resonance energy transfer

Rare Launches SHINE Community Solar Initiative to Bring Green Jobs, Lower Energy Bills to Greater Boston’s Underserved Communities

Retrieved on: 
Wednesday, September 6, 2023

The initiative will also advance the transition to clean energy needed to meet societal, federal, state, and municipal climate objectives.

Key Points: 
  • The initiative will also advance the transition to clean energy needed to meet societal, federal, state, and municipal climate objectives.
  • Increase community solar generation capacity within marginalized communities, providing locally produced resilient power while making community solar visible—a key behavioral strategy to encourage adoption.
  • The SHINE initiative puts an inclusive antipoverty strategy at the forefront of its mission, which supports economic equity at the individual level and benefits the community.
  • The initiative will create greater access to renewable energy in low-income communities and will support opportunities in the renewable energy workforce.”
    For more information about SHINE, please visit: https://rare.org/program/climate-culture/solar-helping-ignite-neighborho... .

Global Live Cell Imaging Markets, 2022-2027 - Opportunities in Applications of HCS in Personalized Medicine - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 27, 2022

The Global Live Cell Imaging Market is estimated to be USD 2.07 Bn in 2022 and is projected to reach USD 2.99 Bn by 2027, growing at a CAGR of 7.6%.

Key Points: 
  • The Global Live Cell Imaging Market is estimated to be USD 2.07 Bn in 2022 and is projected to reach USD 2.99 Bn by 2027, growing at a CAGR of 7.6%.
  • Market dynamics are forces that impact the prices and behaviors of the Global Live Cell Imaging Market stakeholders.
  • The report presents a detailed Ansoff matrix analysis for the Global Live Cell Imaging Market.
  • The report analyses the Global Live Cell Imaging Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Anixa Biosciences and MolGenie Announce Early Potency Analysis of SARS-CoV-2 Protease Inhibitor

Retrieved on: 
Monday, January 24, 2022

"We're pleased to report additional progress on our COVID-19 program," said Dr. Amit Kumar, President, CEO and Chairman of Anixa Biosciences.

Key Points: 
  • "We're pleased to report additional progress on our COVID-19 program," said Dr. Amit Kumar, President, CEO and Chairman of Anixa Biosciences.
  • The results from this head-to-head in vitro analysis suggest that our compound may be more effective than the authorized protease inhibitors.
  • Since the crystal structure of Mpro of SARS-CoV-2 was published, Anixa has worked in partnership with MolGenie to identify compounds that could inhibit this enzyme.
  • This head-to-head analysis with nirmatrelvir is an encouraging early sign of the validity of our strategy.

Live Cell Imaging Markets - Global Forecast to 2027: Market is Anticipated to Grow at the Rate of 8.9% - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 3, 2021

Many researchers have broadly accepted the technology of live cell imaging to gain better knowledge about cell biology in the past few years.

Key Points: 
  • Many researchers have broadly accepted the technology of live cell imaging to gain better knowledge about cell biology in the past few years.
  • However, the cost of implementing live cell imaging is huge, which is acting as a constraint for the market growth.
  • Moreover, cell biologists use live cell imaging to understand the basic cellular structures and their interaction on the tissue level.
  • Escalating demand of live cell imaging systems in drug discovery and government investments for evolution and advancements in live cell imaging systems are few major factors driving the growth of the global live cell imaging market.

Under the Scanner: Gwangju Institute of Science and Technology Scientists Unravel the Inner Workings of DNA Repair Enzymes

Retrieved on: 
Tuesday, September 14, 2021

Unravelling the DNA repair mechanism opens possibilities for cancer detection and targeted gene repair.

Key Points: 
  • Unravelling the DNA repair mechanism opens possibilities for cancer detection and targeted gene repair.
  • In such a scenario, a set of enzymes (proteins that act as catalysts for biochemical reactions) are activated to repair the damage.
  • The sequence of processes undertaken by the enzymes to fix DNA damage is known as "base excision repair" (BER).
  • "This study provides insights for investigation of operational mechanisms of other enzymes involved in DNA repair.

Live Cell Imaging Market worth $2.8 billion by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, October 29, 2020

Based on type, the live cell imaging consumables market is segmented into reagents, media, assay kits, and other consumables (microplates, slides, Petri dishes, coverslips, and culture chambers).

Key Points: 
  • Based on type, the live cell imaging consumables market is segmented into reagents, media, assay kits, and other consumables (microplates, slides, Petri dishes, coverslips, and culture chambers).
  • In 2019, the reagents segment accounted for the largest share of 36.1% of the consumables market.
  • Based on technology, the live cell imaging market is segmented into fluorescence resonance energy transfer (FRET), time-lapse microscopy, fluorescence recovery after photobleaching (FRAP), high-content screening (HCS), and other technologies.
  • Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=163914483
    North America is expected to account for the largest share of the live cell imaging market in 2019, followed by Europe.

Live Cell Imaging Market worth $2.8 billion by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, October 29, 2020

Based on type, the live cell imaging consumables market is segmented into reagents, media, assay kits, and other consumables (microplates, slides, Petri dishes, coverslips, and culture chambers).

Key Points: 
  • Based on type, the live cell imaging consumables market is segmented into reagents, media, assay kits, and other consumables (microplates, slides, Petri dishes, coverslips, and culture chambers).
  • In 2019, the reagents segment accounted for the largest share of 36.1% of the consumables market.
  • Based on technology, the live cell imaging market is segmented into fluorescence resonance energy transfer (FRET), time-lapse microscopy, fluorescence recovery after photobleaching (FRAP), high-content screening (HCS), and other technologies.
  • Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=163914483
    North America is expected to account for the largest share of the live cell imaging market in 2019, followed by Europe.

ProciseDx Files 510k and Prepares for EU launch of Novel Point of Care Technology

Retrieved on: 
Tuesday, May 12, 2020

Procise CRP is the first of a series of 2-5 minute lab-quality tests what will be launched on the ProciseDx instrument.

Key Points: 
  • Procise CRP is the first of a series of 2-5 minute lab-quality tests what will be launched on the ProciseDx instrument.
  • "We're delighted with the robust performance we've been able to demonstrate in our CRP 510k clinical trials," said Larry Mimms, CEO and Chief Scientific Officer of ProciseDx.
  • "We believe that using FRET (Florescent Resonance Energy Transfer) technology brings real advantages in clinical practice.
  • Jacques joins ProciseDx with extensive point of care diagnostic commercialization experience, most recently at GenMark, where he was Vice President and General Manager, Europe.

Bioauxilium Introduces THUNDER™, a New Generation of TR‑FRET Cell Signaling Assay Kits

Retrieved on: 
Wednesday, February 19, 2020

Bioauxilium Research Inc. , a Canadian biotech specialized in the development and manufacturing of world-class time-resolved Frster resonance energy transfer (TRFRET) assay kits, announced today the launch of its proprietary no-wash THUNDER TRFRET cellular platform with the introduction of 68 new cell signaling assay kits.

Key Points: 
  • Bioauxilium Research Inc. , a Canadian biotech specialized in the development and manufacturing of world-class time-resolved Frster resonance energy transfer (TRFRET) assay kits, announced today the launch of its proprietary no-wash THUNDER TRFRET cellular platform with the introduction of 68 new cell signaling assay kits.
  • The ready-to-use THUNDER Cell Signaling Assay Kits are based on the higher specificity sandwich immunoassay format.
  • The THUNDER assay kits combine rigorously validated antibodies, the best compatible FRET fluorophores and stringent manufacturing standards to ensure specificity, enhanced TRFRET assay performance and lot-to-lot consistency.
  • Since its inception in 2013, Bioauxilium has licensed hundreds of TRFRET assay kits enabling the quantification of cellular proteins and biomarkers.

ProciseDx and Lumiphore Announce Diagnostic Technology Partnership

Retrieved on: 
Tuesday, October 8, 2019

SAN DIEGO and BERKELEY, Calif., Oct. 8, 2019 /PRNewswire/ -- ProciseDx and Lumiphore announced that they have signed an agreement on incorporation of Lumiphore's new metal luminescent reporter technology in ProciseDx point-of-care diagnostic tests.

Key Points: 
  • SAN DIEGO and BERKELEY, Calif., Oct. 8, 2019 /PRNewswire/ -- ProciseDx and Lumiphore announced that they have signed an agreement on incorporation of Lumiphore's new metal luminescent reporter technology in ProciseDx point-of-care diagnostic tests.
  • Under the agreement, ProciseDx has the exclusive worldwide rights to use Lumiphore's new technology in its diagnostic tests.
  • "Lumiphore can bring the benefits of lanthanide-based homogenous mix-and-read assays, known as time-resolved fluorescence resonance energy transfer (TR-FRET) assays, to the diagnostic markets, from central labs to point-of-care applications.
  • "Using Lumiphore's technology enables ProciseDx to offer rapid, quantitative and easy point-of-care tests.